Advertisement

GI & Endoscopy

Adenoma detection rate benchmarks are currently set at 25 percent for male and 15 percent for female colonoscopy patients. A new study published in The New England Journal of Medicine suggests that these benchmarks may need to be higher, according…

Advertisement

Biopharmaceutical company PAION AG will present two scientific abstracts on Remimazolam as a short acting sedative at the Anesthesiology 2014 Annual Meeting and American College of Gastroenterology Annual Scientific Meeting.  

Last week, biopharmaceutical company Gilead Sciences travelled to Capitol Hill to brief members of Congress on the cost of its hepatitis C drug Sovaldi, according to a Jewish Times report.

Advertisement